Diego Föllmi

Private Investment Firm Schwyz, Switzerland ·Founded 2003

Overview

Diego Föllmi is a Swiss entrepreneur and investor specializing in quality-focused asset management. He serves as the CEO of Hérens Quality Asset Management AG (HQAM), an independent asset management boutique based in Switzerland. Under his leadership, HQAM has been dedicated to investing in financially robust companies with strong market positions and sustainable business models. Prior to his tenure at HQAM, Föllmi gained experience in private banking and asset management divisions at Credit Suisse. He holds a Master of Arts in Banking & Finance from the University of Zurich. His expertise lies in identifying and investing in companies that demonstrate operational excellence and attractive valuations. Föllmi's investment philosophy centers on a comprehensive evaluation of a company's financial health, business model, management quality, and market positioning. This approach aims to achieve long-term growth by focusing on companies with sustainable competitive advantages and responsible resource management.

Investment Focus

  • Financial strength
  • Sustainable business model
  • Attractive valuation

Portfolio Companies

NestléRocheNovartisZurich Insurance GroupABB

Reach Diego Föllmi directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Diego Föllmi

What sectors does Diego Föllmi invest in?

Diego Föllmi invests in Financial Services and Asset Management, and is based in Schwyz, Switzerland. Diego Föllmi is listed as a private investment firm in the ConnectSafely investor database.

What stage does Diego Föllmi invest at?

Diego Föllmi backs companies at Growth and Late Stage, writing cheques of 1M - 50M.

Which regions does Diego Föllmi invest in?

Diego Föllmi invests across Germany, Switzerland, Luxembourg and Austria.

What companies has Diego Föllmi invested in?

Diego Föllmi's portfolio includes Nestlé, Roche, Novartis, Zurich Insurance Group and ABB.

Last updated · Source: ConnectSafely investor database